The Pharmacogenomics Journal - Table of Contents alert Volume 14 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 14, Issue 5 (October 2014) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   A Pharmacogenomic Approach to Targeted Medicine The advent of NGS technology enables comprehensive screening of an individual's genomic variations. However, the interpretation of this data poses a challenge, particularly in a clinical context. The PGMD database provides a comprehensive resource for all variants that have been reported as significant in a pharmacogenomic context in human studies. Learn more. Advertisement Now open for submissions, Scientific Data is an open access, peer-reviewed publication for descriptions of scientifically valuable datasets. Our primary article-type, the Data Descriptor, is designed to make your data more discoverable, interpretable and reusable, plus we offer data curation advice as part of our service to authors. Submit your data descriptor now!     Review Top Genetic markers for prediction of treatment outcomes in ovarian cancer E Caiola, M Broggini and M Marabese Pharmacogenomics J 2014 14: 401-410; advance online publication, July 8, 2014; 10.1038/tpj.2014.32 Abstract | Full Text Original Articles Top Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations A Corrigan, J L Walker, S Wickramasinghe, M A Hernandez, S J Newhouse, A A Folarin, C M Lewis, J D Sanderson, J Spicer and A M Marinaki Pharmacogenomics J 2014 14: 411-417; advance online publication, April 15, 2014; 10.1038/tpj.2014.13 Abstract | Full Text Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy F Graziano, V Catalano, P Lorenzini, E Giacomini, D Sarti, G Fiorentini, M De Nictolis, M Magnani and A Ruzzo Pharmacogenomics J 2014 14: 418-423; advance online publication, March 25, 2014; 10.1038/tpj.2014.11 Abstract | Full Text The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis M M Dias, J-P Pignon, C S Karapetis, V Boige, B Glimelius, D M Kweekel, P N Lara, P Laurent-Puig, E Martinez-Balibrea, D Páez, C J A Punt, M W Redman, G Toffoli, M Wadelius, R A McKinnon and M J Sorich Pharmacogenomics J 2014 14: 424-431; advance online publication, April 8, 2014; 10.1038/tpj.2014.16 Abstract | Full Text Association between methylenetetrahydrofolate reductase polymorphisms and the relapse of acute lymphoblastic leukemia: a meta-analysis H-R He, S-Y Chen, H-S You, S-S Hu, J-Y Sun, Y-L Dong and J Lu Pharmacogenomics J 2014 14: 432-438; advance online publication, March 18, 2014; 10.1038/tpj.2014.10 Abstract | Full Text A multi-marker molecular signature approach for treatment-specific subgroup identification with survival outcomes L Li, T Guennel, S Marshall and L W-K Cheung Pharmacogenomics J 2014 14: 439-445; advance online publication, March 18, 2014; 10.1038/tpj.2014.9 Abstract | Full Text A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease D L Foley and A Mackinnon Pharmacogenomics J 2014 14: 446-451; advance online publication, March 11, 2014; 10.1038/tpj.2014.8 Abstract | Full Text Effect of risperidone metabolism and P-glycoprotein gene polymorphism on QT interval in patients with schizophrenia Y Suzuki, N Tsuneyama, N Fukui, T Sugai, J Watanabe, S Ono, M Saito, Y Inoue and T Someya Pharmacogenomics J 2014 14: 452-456; advance online publication, March 4, 2014; 10.1038/tpj.2014.6 Abstract | Full Text Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients P Gassó, N Rodríguez, S Mas, M Pagerols, A Blázquez, M T Plana, M Torra, L Lázaro and A Lafuente Pharmacogenomics J 2014 14: 457-462; advance online publication, March 25, 2014; 10.1038/tpj.2014.12 Abstract | Full Text PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway C Fabbri, A Marsano, D Albani, A Chierchia, R Calati, A Drago, C Crisafulli, M Calabrò, S Kasper, R Lanzenberger, J Zohar, A Juven-Wetzler, D Souery, S Montgomery, J Mendlewicz and A Serretti Pharmacogenomics J 2014 14: 463-472; advance online publication, April 8, 2014; 10.1038/tpj.2014.15 Abstract | Full Text Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct? P W Payne Pharmacogenomics J 2014 14: 473-480; advance online publication, April 22, 2014; 10.1038/tpj.2014.14 Abstract | Full Text A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine S Rädisch, D Dickens, T Lang, L Bonnett, R Arlanov, M R Johnson, M Schwab, A G Marson and M Pirmohamed Pharmacogenomics J 2014 14: 481-487; advance online publication, February 25, 2014; 10.1038/tpj.2014.5 Abstract | Full Text Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients M Chen, C Hu, R Zhang, F Jiang, J Wang, D Peng, S Tang, X Sun, J Yan, Y Luo, Y Bao and W Jia Pharmacogenomics J 2014 14: 488-492; advance online publication, April 22, 2014; 10.1038/tpj.2014.18 Abstract | Full Text Advertisement Scientific Data will be attending the American Society of Human Genetics conference on 19th - 21st October. Come and see us at the Nature booth 1321-1323 to learn more.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.